Chemotherapy for Cancer Patients With Alzheimer's Disease
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Chemotherapy for cancer patients with Alzheimer's disease
Numerator
Number of people who died with Alzheimer's disease and had a cancer diagnosis and received chemotherapy in the [12, 6] months prior to death
Denominator
Number of people who died with Alzheimer's disease and had a cancer diagnosis
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
De Schreye, R., Houttekier, D., Deliens, L., & Cohen, J. (2017). Developing indicators of appropriate and inappropriate end-of-life care in people with Alzheimer's disease, cancer or chronic obstructive pulmonary disease for population-level administrative databases: A RAND/UCLA appropriateness study. Palliative Medicine, 31(10), 932-945. doi:https://dx.doi.org/10.1177/0269216317705099 De Schreye, R., Smets, T., Deliens, L., Annemans, L., Gielen, B., & Cohen, J. (2020). Appropriateness of End-of-Life Care in People Dying With Dementia: Applying Quality Indicators on Linked Administrative Databases. Journal of the American Medical Directors Association, 21(8), 1093-1101